Superworth

Linde LIN

Chemicals - Specialty, Basic Materials
$515.67
−0.78%
Market cap
$237.7B
PE
34.3×
10y median 34.4×
Forward PE
26.9×
10y median 26.3×
Price to sales
6.6×
EV/EBIT
29.3×
Revenue, 12 months
$36.2B
+8% on a year ago
Net margin
19.3%
Free cash flow yield
n/m
Q3 FY26 missing

Linde trades at 34.3× trailing earnings, near its ten-year median. Revenue was $36.2B over the last twelve months, up 8% on a year earlier with a 19% net margin.

Charts

Financials

Income statement for LIN, by quarter
Income statementQ4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
$8.3B+5%$8.1B−1%$8.3B+1%$8.4B+3%$8.3B−0%$8.1B+0%$8.5B+3%$8.6B+3%$8.8B+6%$8.8B+8%$9.3B+9%$9.4B+9%
Cost of revenue$4.4B+0%$4.2B−5%$4.3B−2%$4.4B+1%$4.3B−3%$4.2B−1%$4.3B+1%$4.4B+1%$4.5B+5%$4.5B+9%$4.9B+13%n/a
Gross profit$3.9B+12%$3.9B+3%$4B+3%$4B+4%$4B+2%$4B+2%$4.2B+4%$4.2B+6%$4.2B+6%$4.3B+8%$4.4B+6%n/a
R&D$39M+8%$38M+6%$36M+3%$37M+3%$39M+0%$38M+0%$38M+6%$36M−3%$35M−10%$38M+0%$37M−3%n/a
SG&A$832M+9%$860M+5%$840M+1%$823M+2%$814M−2%$786M−9%$870M+4%$897M+9%$880M+8%$893M+14%$891M+2%n/a
$2B+20%$2.1B+8%$2.2B+9%$2.1B+2%$2.3B+12%$2.2B+4%$2.4B+8%$2.4B+14%$2B−11%$2.4B+12%$2.6B+9%$2.1B−9%
Interest expense$351M+43%$65M+76%$70M+35%$68M+70%$53M−85%$60M−8%$67M−4%$64M−6%$64M+21%$62M+3%$61M−9%n/a
Pre-tax income$2B+17%$2.1B+7%$2.2B+8%$2.1B+1%$2.3B+13%$2.2B+5%$2.3B+9%$2.4B+14%$2B−11%$2.4B+12%$2.5B+9%n/a
$459M+18%$463M+8%$508M+16%$498M+2%$533M+16%$511M+10%$573M+13%$424M−15%$481M−10%$571M+12%$610M+7%n/a
Net income$1.5B+16%$1.6B+7%$1.7B+6%$1.6B−1%$1.7B+12%$1.7B+3%$1.8B+6%$1.9B+25%$1.5B−11%$1.9B+11%$1.9B+9%$1.7B−12%
$3.16+18%$3.35+10%$3.44+8%$3.22+1%$3.60+14%$3.51+5%$3.73+8%$4.09+27%$3.26−9%$3.98+13%$4.15+11%$3.66−11%
488.2M−2%485.6M−2%483.2M−2%480.9M−2%478.8M−2%476.3M−2%473.6M−2%471.5M−2%468.3M−2%466.3M−2%464.5M−2%n/a

Gross profit: 74 periods, Q1 FY08 to Q2 FY26: not printed by the filing, worked out from its own lines.

Net income: 5 periods, Q4 FY09 to Q4 FY23: printed in the fourth-quarter results release.

EPS, diluted: 5 periods, Q4 FY08 to Q4 FY19: quarter's net income to common over its shares, to the cent. 7 periods, Q4 FY09 to Q4 FY25: printed in the fourth-quarter results release.

Diluted shares: 3 periods, Q4 FY08 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. 5 periods, Q4 FY09 to Q4 FY23: printed in the fourth-quarter results release.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet. Figures from older filings without data tags, and from a results release before its 10-Q, are read from the document's text and checked against it.

Estimates

Next earnings report: .

QuarterRevenueRangeEPSRangeAnalysts
Q4 FY26$9.2B$9.1B to $9.4B$4.50$4.45 to $4.5712
Q1 FY27$9.3B$9.2B to $9.3B$4.69$4.63 to $4.743
Q2 FY27$9.7B$9.5B to $9.9B$4.93$4.81 to $5.031
Q3 FY27$9.8B$9.6B to $9.9B$5.01$4.88 to $5.111
Q4 FY27$9.7B$9.5B to $9.9B$4.96$4.83 to $5.051
Q1 FY28$9.8B$9.6B to $9.9B$5.12$4.99 to $5.232
Q2 FY28$10.3B$10.1B to $10.4B$5.37$5.24 to $5.482
Q3 FY28$10.1B$9.9B to $10.3B$5.45$5.31 to $5.562

Peers

Companies in Chemicals - Specialty nearest Linde's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
LINLinde$237.7B34.3×34.4×26.9×6.6×+8%19.3%
ECLEcolab$85.7B41.1×37.4×35.5×5.1×+7%12.6%
SHWSherwin-Williams$84B31.9×33.3×27.0×3.4×+6%11.0%
APDAir Products and Chemicals$69.9Bn/m28.1×22.1×5.5×+5%−0.4%
PPGPPG Industries$27.6B17.8×23.9×15.1×1.7×+5%9.6%
IFFInternational Flavors & Fragrances$23.8B81.9×35.9×27.0×2.4×−5%2.9%
Peer median$69.9B36.5×33.3×27.0×3.4×+5%9.6%

Investors who own it

Investors we follow who held Linde at the end of Jun 30, 2026, from their 13F filings.

More on Linde

Each number over time

Where it ranks

Its groups

About

Industry
Chemicals - Specialty
Sector
Basic Materials

Valuation data, not investment advice. Prices as of .